Alternative for Analysis of Pharmaceutical Merchandise – Antituberculosis Medicines
12 February 2024
The World Fund invitations producers of pharmaceutical merchandise to submit an Expression of Curiosity (EoI) to have their merchandise evaluated by the Skilled Overview Panel for pharmaceutical merchandise (ERP). This analysis will focus significantly on Antituberculosis medicines:
Rifapentine 150 mg, pill (scored and dispersible)
Rifapentine / Isoniazid / Moxifloxacin, 300 mg / 75 mg / 100mg pill
Rifapentine / Isoniazid / Moxifloxacin / Pyrazinamide, 300 mg / 75 mg / 100mg / 375 mg pill
Detailed details about the assessment course of and submission necessities could be discovered on the Skilled Overview Panel web page.
That is an open invitation and the submission of an expression of curiosity is feasible at any time.
Invitation to Producers to Submit an Expression of Curiosity for Product Analysis by the World Fund Skilled Overview Panel for Pharmaceutical Productsdownload in English
